Ethical Implications of Nutrition Therapy at the End of Life

被引：3

作者：

Bower K.L. ^{[1
,5
]}

Shilling D.M. ^{[2
]}

Bonnes S.L. ^{[2
]}

Shah A. ^{[3
]}

Lawson C.M. ^{[4
]}

Collier B.R. ^{[1
]}

Whitehead P.B. ^{[5
]}

机构：

[1] Carilion Clinic, Department of Surgery, Virginia Tech Carilion School of Medicine, 1906 Belleview Ave., Roanoke, 24014, VA

[2] Mayo Clinic, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN

[3] Cooper University Health Care, Cooper Medical School of Rowan University Digestive Health Institute, Camden, NJ

[4] Division of Trauma and Critical Care Surgery, Univeristy of Tennessee, Knoxville, TN

[5] Carilion Clinic Palliative Medicine, Virginia Tech Carilion School of Medicine, 1906 Belleview Ave, Roanoke, 24014, VA

来源：

Current Gastroenterology Reports | 2023年 / 25卷 / 3期

关键词：

Artificial nutrition; End of life; Enteral nutrition; Ethics; Medically administered nutrition; Parenteral nutrition; Shared decision-making;

D O I：

10.1007/s11894-023-00862-z

中图分类号：

学科分类号：

摘要：

Purpose of Review: Provide an evidence-based resource to inform ethically sound recommendations regarding end of life nutrition therapy. Recent Findings: • Some patients with a reasonable performance status can temporarily benefit from medically administered nutrition and hydration(MANH) at the end of life. • MANH is contraindicated in advanced dementia. • MANH eventually becomes nonbeneficial or harmful in terms of survival, function, and comfort for all patients at end of life. • Shared decision-making is a practice based on relational autonomy, and the ethical gold standard in end of life decisions. Summary: A treatment should be offered if there is expectation of benefit, but clinicians are not obligated to offer non-beneficial treatments. A decision to proceed or not should be based on the patient’s values and preferences, a discussion of all potential outcomes, prognosis for given outcomes taking into consideration disease trajectory and functional status, and physician guidance provided in the form of a recommendation. © 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

引用

页码：69 / 74

页数：5

共 60 条

[41]

Ukleja A., Romano M.M., Complications of parenteral nutrition, Gastroenterol Clin N Am, 36, 1, pp. 23-46, (2007)

[42]

Dibb M., Teubner A., Theis V., Shaffer J., Lal S., Review article: The management of long-term parenteral nutrition, Aliment Pharmacol Ther, pp. 587-603, (2013)

[43]

Dibb M., Lal S., Monitoring long-term parenteral nutrition, Curr Opin Gastroenterol: Lippincott Williams and Wilkins, pp. 119-125, (2019)

[44]

Mackenzie M.L., Gramlich L., Home parenteral nutrition in advanced cancer: Where are we?, Appl Physiol Nutr Metab, pp. 1-11, (2008)

[45]

Martins A.S., Rezende N.A., Torres H.O., Occurrence of complications and survival rates in elderly with neurological disorders undergoing enteral nutrition therapy, Rev Assoc Med Bras (1992), 58, 6, pp. 691-697, (2012)

[46]

Worthington P., Balint J., Bechtold M., Bingham A., Chan L.N., Durfee S., Et al., When Is Parenteral Nutrition Appropriate?, JPEN J Parenter Enteral Nutr, 41, 3, pp. 324-377, (2017)

[47]

Care P., Zi K., Chua Y., Li E., Quah Y., Lim Y.X., Et al., A systematic scoping review on patients ’ perceptions of dignity, BMC Palliat Care: Biomed Central, (2022)

[48]

Jonsen A.R., Siegler M., Winslade W.J., Clinical ethics: A practical approach to ethical decisions in clinical medicine, (2022)

[49]

Cervo F.A., Bryan L., Farber S., To PEG or not to PEG: A review of evidence for placing feeding tubes in advanced dementia and the decision-making process, Geriatrics, 61, 6, pp. 30-35, (2006)

[50]

Brett A.S., Jersild P., Inappropriate" treatment near the end of life: conflict between religious convictions and clinical judgment, Arch Intern Med, 163, 14, pp. 1645-1649, (2003)

← 1 2 3 4 5 6 →